COLON CANCER 
Hamad Emad H. Dhuhayr
CONTENTS 
• SOEPEL 
• COLON CANCER
SOEPEL 
• S A 60-year-old female patient was admitted to hospital for dyspnea, chest pain, fatigue 
and recurrent plural effusion from 1 year. 
• O taking history and physical examination. 
• E chronic heart failure, renal failure and cirrhosis 
• P Echo and ecg 
• E medication. 
• L colon cancer
COLORECTAL CANCER
DEFINITION 
• Third most common type of cancer and second most 
frequent cause of cancer-related death 
• A disease in which normal cells in the lining of the colon 
or rectum begin to change, grow without control, and no 
longer die 
• Usually begins as a noncancerous polyp that can, over 
time, become a cancerous tumor
TYPICAL SITES OF INCIDENCE AND SYMPOMS 
OF COLON CANCER
RISK FACTOR 
• Polyps (a noncancerous or precancerous growth associated with 
aging) 
• Age 
• Inflammatory bowel disease (IBD) 
• Diet high in saturated fats, such as red meat 
• Personal or family history of cancer 
• Obesity 
• Smoking 
• alcohol
Development of CRC 
Result of interplay between environmental and 
Genetic factors 
Central environmental factors: 
Diet and lifestyle 
35% of all cancers are attributable to diet 
50%-75% of crc in the us may be preventable 
Through dietary modifications
Dietary factors implicated in 
colorectal carcinogenesis 
consumption of red meat 
animal and saturated fat 
refined carbohydrates 
alcohol 
increased risk
Dietary factors implicated in 
colorectal carcinogenesis 
dietary fiber 
vegetables 
fruits 
antioxidant vitamins 
calcium 
folate (B Vitamin) 
decreased risk
HEREDITARY COLORECTAL CANCER 
SYNDROMES: 
• Familial syndromes such as familial adenomatous polyposis. 
• (FAP)—an autosomal dominant disorder caused by mutations in 
the adenomatous polyposis Coli (APC) gene on chromosome 5— 
may lead to an increased risk of colon cancer. 
• In FAP, Cancers commonly develop in adolescence and young 
adulthood, and the incidence of colorectal Neoplasms is nearly 
100% by age 50 years.
CONT…. 
• Hereditary nonpolyposis colon cancer. 
• (HNPCC or lynch syndrome) is associated with a lower but 
significant risk of cancer of the Colon and rectum. 
• Mutations in tumor suppressor genes such as MCC, DCC, BRCA1, 
and p53 
• Also confer higher risks for colorectal neoplasms.
SCREENING 
• A. Adults with signs or symptoms consistent with colorectal neoplasm should 
undergo testing To exclude the presence of a mass. 
• B. All average-risk adults aged 50 years or older should undergo one or more of 
the following: annual Fecal occult blood test (FOBT) or fecal immunochemical 
test (FIT), flexible sigmoidoscopy every 5 years, double-contrast barium enema 
(DCBE) every 5 years, CT colonography every 5 years, or Colonoscopy every 10 
years. All positive tests should be followed up with a colonoscopy. 
• C. High-risk patients, including those with a personal or family history of 
colorectal cancer or Adenomatous polyps, a history of FAP or HNPCC, or a 
history of inflammatory bowel disease, Should be screened earlier and more 
frequently.
PATHOLOGY 
• A. The large majority of colorectal neoplasms are 
adenocarcinomas, and most are well or moderately differentiated. 
Poorly differentiated neoplasms are associated with poor 
prognosis. 
• B. Squamous cell carcinomas can arise in the anus. Such 
neoplasms differ from adenocarcinomas in terms of biology and 
therapy.
DIAGNOSIS 
• Colonoscopy is the preferred diagnostic test for colorectal cancer 
• Barium enema and fl exible sigmoidoscopy. 
• Biopsy of suspicious lesions is required to establish a diagnosis. 
• Tumor markers such as carcinoembryonic antigen (cea) or 
carbohydrate antigen (ca). 
• Radiologic studies are used to evaluate the extent of local disease 
and to screen for metastatic disease.
STAGE 0 COLORECTAL CANCER 
• Known as “cancer in situ,” meaning the 
cancer is located in the mucosa (moist 
tissue lining the colon or rectum) 
• Removal of the polyp (polypectomy) is 
the usual treatment
STAGE I COLORECTAL CANCER 
• The cancer has grown through the 
mucosa and invaded the muscularis 
(muscular coat) 
• Treatment is surgery to remove the 
tumor and some surrounding lymph 
nodes
STAGE II COLORECTAL CANCER 
• The cancer has grown 
beyond the muscularis of 
the colon or rectum but 
has not spread to the 
lymph nodes 
• Stage ii colon cancer is 
treated with surgery and, 
in some cases, 
chemotherapy after 
surgery 
• Stage ii rectal cancer is 
treated with surgery, 
radiation therapy, and 
chemotherapy
STAGE III COLORECTAL CANCER 
• The cancer has spread to 
the regional lymph nodes 
(lymph nodes near the 
colon and rectum) 
• Stage iii colon cancer is 
treated with surgery and 
chemotherapy 
• Stage iii rectal cancer is 
treated with surgery, 
radiation therapy, and 
chemotherapy
STAGE IV COLORECTAL CANCER 
• The cancer has spread 
outside of the colon or 
rectum to other areas of the 
body 
• Stage IV cancer is treated 
with chemotherapy. Surgery 
to remove the colon or rectal 
tumor may or may not be 
done 
• Additional surgery to 
remove metastases may also 
be done in carefully selected 
patients
Dukes staging system 
A Mucosa 80% 
B Into or through M. propria 50% 
C1 Into M. propria, + LN ! 40% 
C2 Through M. propria, + LN! 12% 
D distant metastatic spread <5%
Goals of treatment 
Treatment is defined by stage and type of cancer present 
Goals of treatment for 
early disease 
• Remove cancer cells 
• Kill cancer cells 
• Keep the cancer cells 
from returning 
Goals of treatment for 
advanced disease 
• Slow or stop the growth of 
cancer cells 
• Manage quality of life 
concerns
REFERENCES 
• DAVIDSON’S 
• KUMAR 
• WEBSITE

Colon cancer

  • 1.
    COLON CANCER HamadEmad H. Dhuhayr
  • 2.
    CONTENTS • SOEPEL • COLON CANCER
  • 3.
    SOEPEL • SA 60-year-old female patient was admitted to hospital for dyspnea, chest pain, fatigue and recurrent plural effusion from 1 year. • O taking history and physical examination. • E chronic heart failure, renal failure and cirrhosis • P Echo and ecg • E medication. • L colon cancer
  • 4.
  • 5.
    DEFINITION • Thirdmost common type of cancer and second most frequent cause of cancer-related death • A disease in which normal cells in the lining of the colon or rectum begin to change, grow without control, and no longer die • Usually begins as a noncancerous polyp that can, over time, become a cancerous tumor
  • 6.
    TYPICAL SITES OFINCIDENCE AND SYMPOMS OF COLON CANCER
  • 7.
    RISK FACTOR •Polyps (a noncancerous or precancerous growth associated with aging) • Age • Inflammatory bowel disease (IBD) • Diet high in saturated fats, such as red meat • Personal or family history of cancer • Obesity • Smoking • alcohol
  • 8.
    Development of CRC Result of interplay between environmental and Genetic factors Central environmental factors: Diet and lifestyle 35% of all cancers are attributable to diet 50%-75% of crc in the us may be preventable Through dietary modifications
  • 9.
    Dietary factors implicatedin colorectal carcinogenesis consumption of red meat animal and saturated fat refined carbohydrates alcohol increased risk
  • 10.
    Dietary factors implicatedin colorectal carcinogenesis dietary fiber vegetables fruits antioxidant vitamins calcium folate (B Vitamin) decreased risk
  • 11.
    HEREDITARY COLORECTAL CANCER SYNDROMES: • Familial syndromes such as familial adenomatous polyposis. • (FAP)—an autosomal dominant disorder caused by mutations in the adenomatous polyposis Coli (APC) gene on chromosome 5— may lead to an increased risk of colon cancer. • In FAP, Cancers commonly develop in adolescence and young adulthood, and the incidence of colorectal Neoplasms is nearly 100% by age 50 years.
  • 12.
    CONT…. • Hereditarynonpolyposis colon cancer. • (HNPCC or lynch syndrome) is associated with a lower but significant risk of cancer of the Colon and rectum. • Mutations in tumor suppressor genes such as MCC, DCC, BRCA1, and p53 • Also confer higher risks for colorectal neoplasms.
  • 13.
    SCREENING • A.Adults with signs or symptoms consistent with colorectal neoplasm should undergo testing To exclude the presence of a mass. • B. All average-risk adults aged 50 years or older should undergo one or more of the following: annual Fecal occult blood test (FOBT) or fecal immunochemical test (FIT), flexible sigmoidoscopy every 5 years, double-contrast barium enema (DCBE) every 5 years, CT colonography every 5 years, or Colonoscopy every 10 years. All positive tests should be followed up with a colonoscopy. • C. High-risk patients, including those with a personal or family history of colorectal cancer or Adenomatous polyps, a history of FAP or HNPCC, or a history of inflammatory bowel disease, Should be screened earlier and more frequently.
  • 14.
    PATHOLOGY • A.The large majority of colorectal neoplasms are adenocarcinomas, and most are well or moderately differentiated. Poorly differentiated neoplasms are associated with poor prognosis. • B. Squamous cell carcinomas can arise in the anus. Such neoplasms differ from adenocarcinomas in terms of biology and therapy.
  • 15.
    DIAGNOSIS • Colonoscopyis the preferred diagnostic test for colorectal cancer • Barium enema and fl exible sigmoidoscopy. • Biopsy of suspicious lesions is required to establish a diagnosis. • Tumor markers such as carcinoembryonic antigen (cea) or carbohydrate antigen (ca). • Radiologic studies are used to evaluate the extent of local disease and to screen for metastatic disease.
  • 19.
    STAGE 0 COLORECTALCANCER • Known as “cancer in situ,” meaning the cancer is located in the mucosa (moist tissue lining the colon or rectum) • Removal of the polyp (polypectomy) is the usual treatment
  • 20.
    STAGE I COLORECTALCANCER • The cancer has grown through the mucosa and invaded the muscularis (muscular coat) • Treatment is surgery to remove the tumor and some surrounding lymph nodes
  • 21.
    STAGE II COLORECTALCANCER • The cancer has grown beyond the muscularis of the colon or rectum but has not spread to the lymph nodes • Stage ii colon cancer is treated with surgery and, in some cases, chemotherapy after surgery • Stage ii rectal cancer is treated with surgery, radiation therapy, and chemotherapy
  • 22.
    STAGE III COLORECTALCANCER • The cancer has spread to the regional lymph nodes (lymph nodes near the colon and rectum) • Stage iii colon cancer is treated with surgery and chemotherapy • Stage iii rectal cancer is treated with surgery, radiation therapy, and chemotherapy
  • 23.
    STAGE IV COLORECTALCANCER • The cancer has spread outside of the colon or rectum to other areas of the body • Stage IV cancer is treated with chemotherapy. Surgery to remove the colon or rectal tumor may or may not be done • Additional surgery to remove metastases may also be done in carefully selected patients
  • 24.
    Dukes staging system A Mucosa 80% B Into or through M. propria 50% C1 Into M. propria, + LN ! 40% C2 Through M. propria, + LN! 12% D distant metastatic spread <5%
  • 25.
    Goals of treatment Treatment is defined by stage and type of cancer present Goals of treatment for early disease • Remove cancer cells • Kill cancer cells • Keep the cancer cells from returning Goals of treatment for advanced disease • Slow or stop the growth of cancer cells • Manage quality of life concerns
  • 26.
    REFERENCES • DAVIDSON’S • KUMAR • WEBSITE